Republicans in the US Senate have said they will spare the US-backed HIV/Aids programme Pepfar from cuts, amid a larger ...

A larger role for China, perhaps, and the fraught issue of integrating HIV services into services for other diseases.

The administration made a deal with Senate Republicans to remove $400 million in proposed cuts to the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).

The rescissions package, a Trump Administration initiative under the Department of Government Efficiency (DOGE), aims to ...

Juan Michael Porter II, an HIV advocate and patient, warned that the cuts could trigger a return to the crisis of earlier decades, when effective treatment was unavailable or out of reach.

Explore the implications of Trump funding cuts on foreign aid and public broadcasting. What does this mean for the budget?

GSK has expanded its voluntary licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) for cabotegravir, allowing it to be produced by three generic drugmakers and supplied to ...

The Trump administration has asked Congress to rescind funds for NPR/PBS and foreign aid. Congress has until the end of the ...

GENEVA, 15 July 2025–Lenacapavir–a long-acting, six-monthly injectable antiretroviral medicine manufactured by Gilead Sciences–is now recommended by the World Health Organization as an additional HIV ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

The proposed cuts have caused concerns among some Senate Republicans, including Utah Sen. John Curtis, who may consider ...

As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...